Sibutramine: Balancing weight toss benefit and possible cardiovascular risk

被引：20

作者：

de Simone, Giovanni ^{[1
]}

D'Addeo, Gianpaoto ^{[1
]}

机构：

[1] Univ Naples Federico 2, Dept Clin & Expt Med, I-80131 Naples, Italy

来源：

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | 2008年 / 18卷 / 05期

关键词：

D O I：

10.1016/j.numecd.2008.03.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：337 / 341

页数：5

共 48 条

[31] Sibutramine: A serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity [J].

Luque, CA ;

Rey, JA .

ANNALS OF PHARMACOTHERAPY, 1999, 33 (09) :968-978

[32] THE CONTRIBUTION OF METABOLITES TO THE RAPID AND POTENT DOWN-REGULATION OF RAT CORTICAL BETA-ADRENOCEPTORS BY THE PUTATIVE ANTIDEPRESSANT SIBUTRAMINE HYDROCHLORIDE [J].

LUSCOMBE, GP ;

HOPCROFT, RH ;

THOMAS, PC ;

BUCKETT, WR .

NEUROPHARMACOLOGY, 1989, 28 (02) :129-134

[33] Orlistat and sibutramine beyond weight toss [J].

Mannucci, Edoardo ;

Dicembrini, Ilaria ;

Rotella, Francesco ;

Rotella, Carlo Maria .

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (05) :342-348

[34] Efficacy and safety of sibutramine in obese white and African American patients with hypertension -: A 1-year, double-blind, placebo-controlled, multicenter trial [J].

McMahon, FG ;

Fujioka, K ;

Singh, BN ;

Mendel, CM ;

Rowe, E ;

Rolston, K ;

Johnson, F ;

Mooradian, AD .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (14) :2185-2191

[35] Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors [J].

McMahon, FG ;

Weinstein, SP ;

Rowe, E ;

Ernst, KR ;

Johnson, F ;

Fujioka, K .

JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (01) :5-11

[36]

Perchenet L, 2001, J PHARMACOL EXP THER, V298, P1108

[37] One-year outcome of a combination of weight loss therapies for subjects with type 2 diabetes - A radomized trial [J].

Redmon, JB ;

Raatz, SK ;

Reck, KP ;

Swanson, JE ;

Kwong, CA ;

Fan, Q ;

Thomas, W ;

Bantle, JP .

DIABETES CARE, 2003, 26 (09) :2505-2511

[38] Optimal treatment of obesity-related hypertension - The Hypertension-Obesity-Sibutramine (HOS) Study [J].

Scholze, Juergen ;

Grimm, Elmar ;

Herrmann, Dana ;

Unger, Thomas ;

Kintscher, Ulrich .

CIRCULATION, 2007, 115 (15) :1991-1998

[39] Short-term sibutramine therapy is associated with weight loss and improved endothelial function in obese patients with coronary artery disease [J].

Shechter, Michael ;

Beigel, Roy ;

Freimark, Dov ;

Matetzky, Shlomi ;

Feinberg, Micha S. .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (11) :1650-1653

[40] Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial [J].

Torp-Pedersen, Christian ;

Caterson, Ian ;

Coutinho, Walmir ;

Finer, Nick ;

Van Gaal, Luc ;

Maggioni, Aldo ;

Sharma, Arya ;

Brisco, Wygenia ;

Deaton, Roger ;

Shepherd, Gillian ;

James, Philip .

EUROPEAN HEART JOURNAL, 2007, 28 (23) :2915-2923

← 1 2 3 4 5 →